Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Maj 2020

Planlagt Fastgjort Låst Flyttet Genmab
2.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #1257

    Educational theme | Monoclonal antibodies for the treatment of multiple myeloma https://multiplemyelomahub.com/medical-information/educational-theme-monoclonal-antibodies-for-the-treatment-of-multiple-myeloma

    1 Reply Last reply
    0
    • SolsenS Offline
      SolsenS Offline
      Solsen
      wrote on sidst redigeret af
      #1258

      ADCs IPO i $19 https://finance.yahoo.com/m/aa62ce39-db78-3b7c-9bda-53e4c6e4d971/adc-therapeutics-prices-ipo.html

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #1259

        https://www.fiercebiotech.com/biotech/what-pandemic-adc-s-233m-listing-biotech-ipos-keep-rolling this has a bit more on Cami

        1 Reply Last reply
        0
        • K Offline
          K Offline
          kkjoel
          wrote on sidst redigeret af
          #1260

          Tak EL. Rart med opsummering af mAb feltet/stofferne indenfor MM.. for os der ikke er helt stive i det hele 🙂

          1 Reply Last reply
          0
          • K Offline
            K Offline
            kkjoel
            wrote on sidst redigeret af
            #1261

            Fandt nedenståen i securities filingen fra ADC - ikke uinteressant vist, der blev talt om det herinde for nylig (GENs mulighed for at forhandle de 25%). https://www.sec.gov/Archives/edgar/data/1771910/000114036120009738/nt10009045x3_f1.htm

            1 Reply Last reply
            0
            • K Offline
              K Offline
              kkjoel
              wrote on sidst redigeret af
              #1262

              "Risks Related to Our Relationship with Third Parties / Our rights to Cami are subject to our collaboration and license agreement with Genmab, and there can be no assurance that we will maintain the rights to develop or commercialize Cami. / Our collaboration and license agreement with Genmab requires a divestment of Cami, in which Genmab has a 25% interest, following 60 days, and no later than 65 days, after the database lock for the Phase 1/2 clinical trial, which occurred on April 2, 2020."

              1 Reply Last reply
              0
              • K Offline
                K Offline
                kkjoel
                wrote on sidst redigeret af
                #1263

                "See “Business—License and Collaboration Agreements—Genmab Collaboration and License Agreement.” The agreement sets out a defined process to facilitate the divestment of Cami by licensing the rights thereto to a third party, subject to Genmab’s right of first opportunity to negotiate to acquire Cami in full. This process includes the opportunity for both parties to bid for the license rights alongside third parties."

                1 Reply Last reply
                0
                • K Offline
                  K Offline
                  kkjoel
                  wrote on sidst redigeret af
                  #1264

                  "Both parties are required to use commercially reasonable efforts to complete and maximize the value obtained in this process. Therefore, our rights to Cami are subject to our collaboration and license agreement with Genmab, and there can be no assurance that we will apply for regulatory approval of or commercialize Cami."

                  1 Reply Last reply
                  0
                  • K Offline
                    K Offline
                    kkjoel
                    wrote on sidst redigeret af
                    #1265
                    1. forekomst af "Business—License and Collaboration Agreements—Genmab Collaboration and License Agreement"
                    1 Reply Last reply
                    0
                    • K Offline
                      K Offline
                      kkjoel
                      wrote on sidst redigeret af
                      #1266

                      Så gad vide om der SKAL forhandles indenfor de 65 dg fra 02.04, eller om det "partial clinical hold" (omtalt i Fiercebiotech artilen EL linkede til 17:15)
                      gør at det hele udskydes?!

                      1 Reply Last reply
                      0
                      • K Offline
                        K Offline
                        kkjoel
                        wrote on sidst redigeret af
                        #1267
                        1. forekomst...
                          henviste til at interesserede selv kunne fremsøge i nævnte securities filing.
                        1 Reply Last reply
                        0
                        • K Offline
                          K Offline
                          kkjoel
                          wrote on sidst redigeret af
                          #1268

                          I hvert fald vel interessant at GEN har kontraktsikret førsteret for at forhandle cami 100% hjem igen. Nogen der kan sige noget om hvor normal og/eller dyrt det måtte være?

                          1 Reply Last reply
                          0
                          • K Offline
                            K Offline
                            kkjoel
                            wrote on sidst redigeret af
                            #1269

                            Hvis data er gode.. kunne det måske være en fornuftig måde at bruge noget af formuen på?!

                            1 Reply Last reply
                            0
                            • L Offline
                              L Offline
                              lahn1
                              wrote on sidst redigeret af
                              #1270

                              Fik du nogle ADCT Solsen ? den åbnede i $30

                              1 Reply Last reply
                              0
                              • troldmandenT Offline
                                troldmandenT Offline
                                troldmanden
                                wrote on sidst redigeret af
                                #1271

                                Det er hvis meget normalt med sådan en rettighed. At både ADC og Genmab har rettighed til at byde på hele stoffet forud for en ekstern partner

                                1 Reply Last reply
                                0
                                • troldmandenT Offline
                                  troldmandenT Offline
                                  troldmanden
                                  wrote on sidst redigeret af
                                  #1272

                                  Men en clinical hold med sjældne men alvorlige sygdom, så mudre det nok billedet ganske meget. At skulle smide et stort beløb upfront
                                  for at købe den anden part ud

                                  1 Reply Last reply
                                  0
                                  • SolsenS Offline
                                    SolsenS Offline
                                    Solsen
                                    wrote on sidst redigeret af
                                    #1273

                                    Puha det ser svært ud, når 2/47 får en autoimmun sygdom. Dead money kunne jeg frygte. Og cd19 P deres lead program er heller ikke let.

                                    1 Reply Last reply
                                    0
                                    • L Offline
                                      L Offline
                                      lahn1
                                      wrote on sidst redigeret af
                                      #1274

                                      Har heller ikke købt ,men 60% oppe første dag tager jeg gerne på en fredag

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #1275

                                        Det er vildt.

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #1276

                                          ok, one last post before the weekend...

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger